© 1992 Oxford University Press
OTHER |
Identification of a highly polymorphic marker within intron 7 of the ALAS2 gene and suggestion of at least two loci for X-linked sideroblastic anemia
Department of Biochemistry, University of Adelaide Adelaide 1Department of Cytogenetics and Molecular Genetics, Adelaide Children's Hospital North Aaelaide, South Australia, Australia 2Department of Medicine, University of Washington School of Medicine Seattle, WA, USA
*To whom corrspondence should be addressed at: Department of Biochemistry, University of Adelaide, GPO Box 498, Adelaide 5001, South Australia, Australia
Received July 21, 1992; Revised September 17, 1992; Accepted September 17, 1992
We have identified a compound dinucleotide repeat within intron 7 of the human erythroid 5-aminolevulinate synthase (ALAS2) gene with a minimum of 9 alleles and heterozygosity of 78%. ALAS2 was placed on the multipoint linkage map of the X chromosome in the pericentromeric region with the locus order: pter-(DXS255, TFE3, DXSI46)-(DXS14, ALAS2, DXZI)-AR-(DXSI53, DXS159)-qter. Nó recombination was observed between ALAS2 and the centromere marker DXZ1. As ALAS2 has recently been shown to be the defective locus in X-linked pyridoxine-responsive sideroblastic anemia (PRSA), the ALAS2 marker has allowed placement of the gene for PRSA into the multipoint linkage map of the X chromosome. With the previous exclusion of close linkage between DXS14 and sideroblastic anemia with ataxia, our data show that there are at least two loci for X-linked sideroblastic anemia.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
T. C. Cox, L. R. Allen, L. L. Cox, B. Hopwood, B. Goodwin, E. Haan, and G. K. Suthers New mutations in MID1 provide support for loss of function as the cause of X-linked Opitz syndrome Hum. Mol. Genet., October 1, 2000; 9(17): 2553 - 2562. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Meschede, B. Dworniczak, H.M. Behre, E. Nieschlag, and J. Horst No evidence for uniparental disomy of the sex chromosomes in idiopathic male infertility Mol. Hum. Reprod., January 1, 2000; 6(1): 1 - 4. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. D. Cotter, A. May, L. Li, A.I. Al-Sabah, E. J. Fitzsimons, M. Cazzola, and D. F. Bishop Four New Mutations in the Erythroid-Specific 5-Aminolevulinate Synthase (ALAS2) Gene Causing X-Linked Sideroblastic Anemia: Increased Pyridoxine Responsiveness After Removal of Iron Overload by Phlebotomy and Coinheritance of Hereditary Hemochromatosis Blood, March 1, 1999; 93(5): 1757 - 1769. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. H. Surinya, T. C. Cox, and B. K. May Identification and Characterization of a Conserved Erythroid-specific Enhancer Located in Intron 8 of the Human 5-Aminolevulinate Synthase 2 Gene J. Biol. Chem., July 3, 1998; 273(27): 16798 - 16809. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. Mahtani and H. F. Willard Physical and Genetic Mapping of the Human X Chromosome Centromere: Repression of Recombination Genome Res., February 1, 1998; 8(2): 100 - 110. [Abstract] [Full Text] |
||||
![]() |
T. C. Cox, S. S. Bottomley, J. S. Wiley, M. J. Bawden, C. S. Matthews, and B. K. May X-linked Pyridoxine-Responsive Sideroblastic Anemia Due to a Thr388-to-Ser Substitution in Erythroid 5-Aminolevulinate Synthase N. Engl. J. Med., March 10, 1994; 330(10): 675 - 679. [Abstract] [Full Text] |
||||





